Mar 13, 2026 | Blog
Ethics in clinical research has never been a matter of paperwork alone. Yet in practice, ethical quality is still too often judged by whether the right forms were signed, the right approvals were secured, and the protocol was followed on paper. Across African research...
Mar 11, 2026 | Blog
Across Africa, something subtle but important is changing in the way leaders talk about health. For many years, health systems across the continent were largely framed through the lens of global solidarity: donor programs, development assistance, and externally...
Mar 11, 2026 | Blog
When we discuss the advancement of clinical trials in Africa, the conversation often gravitates toward infrastructure: genomic sequencing capacity, biobanking facilities, or electronic data capture systems. While these physical assets are vital, there is an equally...
Mar 10, 2026 | Blog
Global health rhetoric is rich with good intentions. Few terms have been as enduring or as poorly interrogated, as “capacity building”. For decades, it has served as a justification for donor spending, a line item in pharmaceutical industry corporate...
Mar 5, 2026 | Blog
On January 14, 2026, the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA) jointly released ten guiding principles for Good AI Practice (GAIP) in drug development (1). This landmark collaboration signals that artificial...
Feb 27, 2026 | Blog
What if clinical trials were no longer the bottleneck of drug development? For decades, innovation has followed a familiar trajectory. Discovery has advanced rapidly within highly specialized research environments. Development has proceeded through increasingly...
